top of page
Publications
We have significantly contributed to the understanding of health conditions through real-world data analysis. The insights gained from these studies have had a positive impact on clinical practice, leading to more personalised and effective care for patients.
Real-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthma
4 May 2013
Respiratory Medicine
Authors:
David Price, Mike Thomas, John Haughney, Richard A. Lewis, Anne Burden, Julie von Ziegenweidt, Alison Chisholm, Elizabeth V. Hillyer, Christopher J. Corrigan
Keywords:
Covid 19, COPD, Asthma
Characteristics of patients preferring once-daily controller therapy for asthma and COPD: a retrospective cohort study
2 May 2013
primary care respiratory journal
Authors:
David Price, Amanda J Lee, Erika J Sims, Linda Kemp, Elizabeth V Hillyer, Alison Chisholm, Julie von Ziegenweidt, Angela Williams
Keywords:
Asthma, Child, Inhaled corticosteroid, Long-acting β-agonist, Step-up therapy
A UK-Based Cost-Utility Analysis of Indacaterol, A Once-Daily Maintenance Bronchodilator for Patients with COPD, Using Real World Evidence on Resource Use
24 Mar 2013
Applied Health Economics and Health Policy
Authors:
David Price, Yumi Asukai, Jaithri Ananthapavan, Bill Malcolm, Amr Radwan, Ian Keyzor
Keywords:
Asthma, epidemiology, estradiol, estrogens, progestogen
bottom of page
